Viridian Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACLX
Arcellx, Inc. |
$75.01 | $2.72 B | -49.3 | 163 | $107.94 M |
BPMC
Blueprint Medicines Corporation |
$89.54 | $6.47 B | -21.48 | 649 | $508.82 M |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$50.49 | $3.53 B | -11.86 | 437 | $1.04 M |
CYTK
Cytokinetics, Incorporated |
$49.19 | $6.05 B | -9.78 | 498 | $18.47 M |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
ETNB
89bio, Inc. |
$7.82 | $796.91 M | -4.05 | 93 | $0 |
GPCR
Structure Therapeutics Inc. |
$27.50 | $2.47 B | -23.59 | 163 | $0 |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
INZY
Inozyme Pharma, Inc. |
$2.89 | $286.39 M | -3.43 | 67 | $0 |
KURA
Kura Oncology, Inc. |
$8.51 | $1.66 B | -10.03 | 192 | $53.88 M |
MRUS
Merus N.V. |
$42.39 | $3.50 B | -19.38 | 260 | $36.13 M |
NUVL
Nuvalent, Inc. |
$78.09 | $5.11 B | -32.72 | 142 | $0 |
PCVX
Vaxcyte, Inc. |
$85.99 | $7.72 B | -16.54 | 414 | $0 |
PLRX
Pliant Therapeutics, Inc. |
$13.18 | $672.63 M | -3.9 | 171 | $0 |
PTGX
Protagonist Therapeutics, Inc. |
$38.09 | $2.04 B | 13.7 | 126 | $434.43 M |
REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
TERN
Terns Pharmaceuticals, Inc. |
$5.71 | $462.44 M | -5.67 | 66 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
